Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sharda Boiron Laboratories is a specialized pharmaceutical company based in India that focuses on the manufacturing and marketing of homeopathic medicines. The company was established as a strategic joint venture between the Sharda Group and Boiron, the world leader in homeopathic products headquartered in France. It serves as a key provider of standardized homeopathic treatments in the Indian market, offering a wide array of dilutions, mother tinctures, and specialty formulations. Its commercial portfolio features internationally recognized brands such as Oscillococcinum, Arnigel, and Stodal, which address conditions ranging from respiratory infections to musculoskeletal pain. Sharda Boiron operates with a commitment to high manufacturing standards, ensuring that its products meet the rigorous requirements of the homeopathic pharmacopoeia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sharda Boiron Laboratories.